|
시장보고서
상품코드
2148320
심부전용 POC 및 LOC 기기 시장 : 기기 유형별, 검사 유형별, 바이오마커별, 기술별, 용도별, 최종사용자별, 지역별Heart Failure POC and LOC Devices Market, By Device Type, By Test Type, By Biomarker, By Technology, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
심부전용 POC 및 LOC 디바이스 시장 규모는 2026년에 1억 8,570만 달러로 추정되며, 2033년까지 4억 9,840만 달러에 이를 전망입니다. 또한 2026-2033년 CAGR 15.1%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 1억 8,570만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 15.10% | 2033년 시장 규모 예측 : | 4억 9,840만 달러 |
심부전은 심혈관계에서 발생하는 만성적이고 진행성 질환으로, 전 세계적으로 6,400만 명 이상이 앓고 있습니다. 이 질환에서는 심장이 신체의 산소 수요나 대사 수요를 충족시킬 만큼 충분한 혈액을 펌프질하지 못하게 됩니다. 질병 부담이 증가함에 따라 BNP, NT-proBNP, 트로포닌 등의 바이오마커에 대한 신속하고 정확한 진단 솔루션에 대한 수요가 높아지고 있습니다.
포인트 오브 케어(POC) 및 랩 온 칩(LOC) 장치는 응급실, 진료소, 재택 간호 현장에서 신속하고 분산된 심장 검사를 가능하게 합니다. 마이크로플루이딕스 공학, 바이오센서, 나노기술, 디지털 헬스 분야의 발전으로 인해 이러한 기술은 휴대성이 더욱 향상되고 정확하며 효율적으로 변모하고 있으며, 그 결과 현대 심부전 진단 및 모니터링에 대한 기여도가 확대되고 있습니다.
시장 역학
전 세계 심부전용 POC 및 LOC 기기 시장은 심부전 유병률 증가에 더해 고령화 진행, 그리고 고혈압, 당뇨병, 비만, 관상동맥 질환 유병률 증가에 의해 견인되고 있습니다. 분산형 및 환자 중심의 진료에 대한 관심이 높아지고, 마이크로플루이딕스공학, 바이오센서, 무선 연결, 인공지능의 발전으로 인해 응급실, 외래 진료, 원격의료 현장에서 신속하고 정확한 심장 진단에 대한 수요가 더욱 증가하고 있습니다.
그러나 시장에는 높은 개발 및 제조 비용, 엄격한 규제 요건, 정확도에 대한 우려, 제한된 의료 인프라, 보험 환급 관련 과제 등 많은 제약이 존재합니다. 그럼에도 불구하고, 가정 내 심장 모니터링, IoT 연결형 진단, 클라우드 기반 데이터 관리 및 예측 분석에 대한 수요 증가와 더불어 신흥국에서의 의료 접근성 개선이 맞물려 전 세계 심부전 POC 및 LOC 기기 시장에 새로운 성장 기회를 가져올 것입니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설했습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 심부전용 POC 및 LOC 기기 시장의 주요 업체를 분석했습니다.
- 본 보고서에서 얻은 인사이트를 바탕으로 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 모델 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 본 ‘전 세계 심부전용 POC 및 LOC 기기 시장’ 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 심부전용 POC 및 LOC 기기 시장 분석에 활용된 다양한 전략 매트릭스를 활용하여 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 심부전용 POC 및 LOC 기기 시장 : 디바이스 유형별, 2021년-2033년
제5장 세계의 심부전용 POC 및 LOC 기기 시장 : 테스트 유형별, 2021년-2033년
제6장 세계의 심부전용 POC 및 LOC 기기 시장 : 바이오마커별, 2021년-2033년
제7장 세계의 심부전용 POC 및 LOC 기기 시장 : 기술별, 2021년-2033년
제8장 세계의 심부전용 POC 및 LOC 기기 시장 : 용도별, 2021년-2033년
제9장 세계의 심부전용 POC 및 LOC 기기 시장 : 최종사용자별, 2021년-2033년
제10장 세계의 심부전용 POC 및 LOC 기기 시장 : 지역별, 2021년-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌 및 조사 방법
LSH 26.10.20Heart Failure POC and LOC Devices Market is estimated to be valued at USD 185.7 Mn in 2026 and is expected to reach USD 498.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 15.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 185.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 15.10% | 2033 Value Projection: | USD 498.4 Mn |
Heart failure is a chronic, progressive disease of the cardiovascular system affecting more than 64 million people worldwide, where the heart fails to pump sufficient blood to meet the body's oxygen and metabolic needs. The increasing disease burden is driving the need for rapid and accurate diagnostic solutions for biomarkers such as BNP, NT-proBNP, troponin.
Point-of-Care (POC) and Lab-on-Chip (LOC) devices are enabling rapid and decentralized cardiac testing in emergency departments, clinics, and home-care settings. Progress in microfluidics, biosensors, nanotechnology, and digital health is making these technologies more portable, accurate, and efficient, thus facilitating their expanding contribution to modern heart-failure diagnosis and monitoring.
Market Dynamics
The global heart failure POC and LOC devices market is driven by increase in the prevalence of heart failure as well as increase in the aging population along with increase in the prevalence of hypertension, diabetes, obesity and coronary artery disease. The increase in the preference for decentralized patient-centric care and advances in microfluidics, biosensors, wireless connectivity and artificial intelligence is further increasing the demand for rapid and accurate cardiac diagnostics in emergency, outpatient and remote-care settings.
However, a number of constraints are present in the market, such as high development and manufacturing costs, strict regulatory requirements, accuracy concerns, limited healthcare infrastructure, and reimbursement challenges. Nevertheless, growing demand for home-based cardiac monitoring, IoT-connected diagnostics, cloud-based data management, and predictive analytics, coupled with improving healthcare access in emerging economies will offer new opportunities for growth in the global heart failure POC and LOC devices market.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global heart failure POC and LOC devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Danaher Corporation, QuidelOrtho Corporation, bioMerieux S.A., Becton, Dickinson and Company, Trinity Biotech plc, Jant Pharmacal Corporation, and Werfen, S.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global heart failure POC and LOC devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global heart failure POC and LOC devices market
Market Segmentation
- Device Type Insights (Revenue, USD Mn, 2021 - 2033)
- Point-of-Care (POC) Devices
- Lab-on-Chip (LOC) Devices
- Test Type Insights (Revenue, USD Mn, 2021 - 2033)
- Proteomic Testing
- Metabolomic Testing
- Genomic Testing
- Biomarker Insights (Revenue, USD Mn, 2021 - 2033)
- BNP/NT-proBNP
- Troponin
- Multi-Biomarker Panels
- Others
- Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Microfluidics
- Array-Based Systems
- Immunoassay-Based Systems
- Others
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Acute Heart Failure Diagnosis
- Chronic Heart Failure Monitoring
- Risk Stratification and Readmission Prevention
- Therapy Optimization
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Specialty Cardiology Centers
- Primary Care and Urgent Care Centers
- Diagnostic Laboratories
- Homecare and Remote Patient Monitoring
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- Danaher Corporation
- QuidelOrtho Corporation
- bioMerieux S.A.
- Becton, Dickinson and Company
- Trinity Biotech plc
- Jant Pharmacal Corporation
- Werfen, S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Heart Failure POC and LOC Devices Market, By Device Type
- Global Heart Failure POC and LOC Devices Market, By Test Type
- Global Heart Failure POC and LOC Devices Market, By Biomarker
- Global Heart Failure POC and LOC Devices Market, By Technology
- Global Heart Failure POC and LOC Devices Market, By Application
- Global Heart Failure POC and LOC Devices Market, By End User
- Global Heart Failure POC and LOC Devices Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Device Type Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Heart Failure POC and LOC Devices Market, By Device Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Point-of-Care (POC) Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Lab-on-Chip (LOC) Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Heart Failure POC and LOC Devices Market, By Test Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Proteomic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Metabolomic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Genomic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Heart Failure POC and LOC Devices Market, By Biomarker, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- BNP/NT-proBNP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Troponin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Multi-Biomarker Panels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Heart Failure POC and LOC Devices Market, By Technology, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Microfluidics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Array-Based Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Immunoassay-Based Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Heart Failure POC and LOC Devices Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Acute Heart Failure Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Chronic Heart Failure Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Risk Stratification and Readmission Prevention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Therapy Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Heart Failure POC and LOC Devices Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Specialty Cardiology Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Primary Care and Urgent Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Homecare and Remote Patient Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global Heart Failure POC and LOC Devices Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd.
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- QuidelOrtho Corporation
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- bioMerieux S.A.
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Trinity Biotech plc
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jant Pharmacal Corporation
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Werfen, S.A.
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
